When the hMSC Meets the AAV(ian) – RoosterGEM’s Tale Continues
In 2022, it’s still early morning in Gene and Cell Therapy Land. Behold! There’s “crowing” interest in the deployment of human mesenchymal stromal/stem cells (hMSCS) as cellular delivery systems for ... More